Goldman Sachs’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.7M | Sell |
1,935,167
-142,828
| -7% | -$494K | ﹤0.01% | 2577 |
|
|
2025
Q1 | $5.44M | Sell |
2,077,995
-627,974
| -23% | -$1.65M | ﹤0.01% | 2679 |
|
|
2024
Q4 | $11.1M | Buy |
2,705,969
+730,504
| +37% | +$3.01M | ﹤0.01% | 2244 |
|
|
2024
Q3 | $14M | Buy |
1,975,465
+490,947
| +33% | +$3.48M | ﹤0.01% | 1989 |
|
|
2024
Q2 | $9.68M | Sell |
1,484,518
-278,630
| -16% | -$1.82M | ﹤0.01% | 2115 |
|
|
2024
Q1 | $14.6M | Buy |
1,763,148
+779,761
| +79% | +$6.47M | ﹤0.01% | 1765 |
|
|
2023
Q4 | $10.8M | Buy |
983,387
+91,782
| +10% | +$1.01M | ﹤0.01% | 2018 |
|
|
2023
Q3 | $7.5M | Sell |
891,605
-397,846
| -31% | -$3.35M | ﹤0.01% | 2186 |
|
|
2023
Q2 | $16.2M | Sell |
1,289,451
-109,648
| -8% | -$1.38M | ﹤0.01% | 1706 |
|
|
2023
Q1 | $23M | Buy |
1,399,099
+125,684
| +10% | +$2.07M | 0.01% | 1424 |
|
|
2022
Q4 | $19M | Sell |
1,273,415
-152,888
| -11% | -$2.28M | ﹤0.01% | 1672 |
|
|
2022
Q3 | $31.9M | Buy |
1,426,303
+466,520
| +49% | +$10.4M | 0.01% | 1252 |
|
|
2022
Q2 | $16.1M | Buy |
959,783
+659,012
| +219% | +$11M | ﹤0.01% | 1773 |
|
|
2022
Q1 | $9M | Sell |
300,771
-142,230
| -32% | -$4.26M | ﹤0.01% | 2325 |
|
|
2021
Q4 | $13.6M | Buy |
443,001
+283,420
| +178% | +$8.7M | ﹤0.01% | 2043 |
|
|
2021
Q3 | $5.03M | Sell |
159,581
-37,157
| -19% | -$1.17M | ﹤0.01% | 2791 |
|
|
2021
Q2 | $7.2M | Sell |
196,738
-769,462
| -80% | -$28.2M | ﹤0.01% | 2515 |
|
|
2021
Q1 | $33.4M | Buy |
966,200
+276,986
| +40% | +$9.58M | 0.01% | 1294 |
|
|
2020
Q4 | $28.6M | Buy |
689,214
+582,855
| +548% | +$24.2M | 0.01% | 1309 |
|
|
2020
Q3 | $4.53M | Buy |
+106,359
| New | +$4.53M | ﹤0.01% | 2445 |
|